Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraabdominal Chloroprocaine for Post-Cesarean Pain
NCT03260972Phase 3Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Jun 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of chloroprocaine in postoperative pain, postoperative nausea and vomiting (PONV), sponsored by Johns Hopkins University. Planned start Jun 2021; status: withdrawn.
02
Drugs
chloroprocaine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03260972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03260972.